Ameritas Investment Partners, Inc.
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1055980
LINCOLN, NE
Position in INDV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$446,693
+$146,526 QoQ
Shares Held
10,887
+10.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#209
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ameritas Investment Partners, Inc. holds $18,421,025 across 38 Drug Manufacturers - Specialty & Generic names. INDV ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
7,812 | $4,232,775 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
18,489 | $3,116,136 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
91,918 | $2,262,101 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
58,617 | $2,032,251 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
17,912 | $1,987,157 | |
| 6 | ALKS |
Alkermes plc.
|
15,222 | $797,632 | |
| 7 | LQDA |
Liquidia Corp
|
6,406 | $510,750 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
10,887 | $446,693 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $446,693 | 10,887 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $300,167 | 9,848 | Shares | Other | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||